Nottinghamshire Area Prescribing Committee
Joint Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Atezolizumab
found
8 matches
Open monograph to display formulary status
BNF Category
Atezolizumab
(Tecentriq
®
)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Links
Link to Drug Section
Link to document
EAMS 00031/0012: Atezolizumab in combination with bevacizumab for the treatment of adult patients with unresectable hepatocellular carcinoma who have received no prior systemic therapy (08.01.05)
NICE TA492: Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (08.01.05)
NICE TA520: Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy (08.01.05)
NICE TA525: Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy. (08.01.05)
NICE TA584:Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer (08.01.05)
NICE TA638: Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer (08.01.05)
NICE TA639: Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer (08.01.05)